IDEXX Laboratories Inc (IDXX)

Return on assets (ROA)

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net income (ttm)	US$ in thousands	845,042	822,728	791,435	699,178	679,089	669,653	663,950	734,553	744,845	756,864	727,848	674,206	581,776	497,482	460,100	436,866	427,720	422,862	407,276	390,261
Total assets	US$ in thousands	3,259,920	3,086,400	2,870,810	2,808,400	2,746,760	2,640,070	2,607,180	2,592,690	2,437,200	2,385,740	2,412,150	2,327,380	2,294,560	2,047,410	1,960,710	1,886,240	1,832,480	1,751,480	1,724,240	1,680,970
ROA		25.92%	26.66%	27.57%	24.90%	24.72%	25.36%	25.47%	28.33%	30.56%	31.72%	30.17%	28.97%	25.35%	24.30%	23.47%	23.16%	23.34%	24.14%	23.62%	23.22%

December 31, 2023 calculation

ROA = Net income (ttm) ÷ Total assets
= $845,042K ÷ $3,259,920K
= 25.92%

Idexx Laboratories, Inc. has exhibited stable and healthy return on assets (ROA) over the past eight quarters. The company's ROA has consistently ranged between 24.72% and 27.57%, indicating strong operational efficiency in generating profits relative to its total assets. This consistent performance suggests that Idexx Laboratories, Inc. has been effectively utilizing its assets to generate earnings for its shareholders. Overall, the company's ROA trend is positive, showcasing its ability to create value for its investors through efficient asset management and profitability.

Peer comparison

Dec 31, 2023

Company name

Symbol

ROA

IDEXX Laboratories Inc

IDXX

25.92%

Lantheus Holdings Inc